Skip to content

A Multicenter Clinical Study on AI-Powered Precision Decision-Making Management for Pancreatic Diseases Using Contrast-Enhanced CT

A Multicenter Clinical Study on AI-Powered Precision Decision-Making Management for Pancreatic Diseases Using Contrast-Enhanced CT

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124249
Enrollment
Unknown
Registered
2026-05-09
Start date
2026-05-11
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

Clinicians group:None

Sponsors

ShangHai ChangHai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. 18-80 years old; 2. Patients with a confirmed clinical diagnosis of pancreatic disease; 3. Patients with available contrast-enhanced CT scans; 4. Patients sign the informed consent form and agree to participate in the research.

Exclusion criteria

Exclusion criteria: 1. Poor image quality caused by factors such as ascites, pancreatic trauma, thoracic/abdominal surgery, and other related conditions. 2. Unable to undergo contrast-enhanced CT due to contraindications such as a known allergy to iodinated contrast media or significant hepatic/renal dysfunction. 3. History of pancreatic surger; 4. Currently participating in another clinical trial; 5. Other conditions that, in the opinion of the investigator, would make the subject unsuitable for participation, include but are not limited to pregnant or lactating women, subjects with severe psychiatric disorders or cognitive impairment, subjects currently participating in or who have recently participated in another clinical trial, or subjects with significant medical conditions or complications that could interfere with the study results.

Design outcomes

Primary

MeasureTime frame
Classification accuracy;

Secondary

MeasureTime frame
Agreement rate with clinical decisions;Percentage decrease in unnecessary surgical procedures;Malignancy miss rate;

Countries

China

Contacts

Public ContactJin Gang

ShangHai ChangHai Hospital

jingang@smmu.edu.cn+86 21 31161628

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026